View in EDS HTML Full Text PDF Full Text

Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.

Saved in:
Bibliographic Details
Title: Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
Authors: Levin N; Triphase Accelerator, San Diego, CA, USA., Spencer A; Alfred Health, Monash University, Melbourne, Australia., Harrison SJ; The Peter MacCallum Cancer Centre, Melbourne, Australia., Chauhan D; Dana Farber Cancer Institute, Boston, MA, USA., Burrows FJ; Triphase Accelerator, San Diego, CA, USA., Anderson KC; Dana Farber Cancer Institute, Boston, MA, USA., Reich SD; Triphase Accelerator, San Diego, CA, USA., Richardson PG; Dana Farber Cancer Institute, Boston, MA, USA., Trikha M; Triphase Accelerator, San Diego, CA, USA.
Source: British journal of haematology [Br J Haematol] 2016 Sep; Vol. 174 (5), pp. 711-20. Date of Electronic Publication: 2016 May 09.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27161872
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Levin+N%22">Levin N</searchLink>; Triphase Accelerator, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Spencer+A%22">Spencer A</searchLink>; Alfred Health, Monash University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Harrison+SJ%22">Harrison SJ</searchLink>; The Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Chauhan+D%22">Chauhan D</searchLink>; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Burrows+FJ%22">Burrows FJ</searchLink>; Triphase Accelerator, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+KC%22">Anderson KC</searchLink>; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Reich+SD%22">Reich SD</searchLink>; Triphase Accelerator, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Dana Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Trikha+M%22">Trikha M</searchLink>; Triphase Accelerator, San Diego, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2016 Sep; Vol. 174 (5), pp. 711-20. <i>Date of Electronic Publication: </i>2016 May 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27161872
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjh.14113
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 711
    Titles:
      – TitleFull: Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Levin N
      – PersonEntity:
          Name:
            NameFull: Spencer A
      – PersonEntity:
          Name:
            NameFull: Harrison SJ
      – PersonEntity:
          Name:
            NameFull: Chauhan D
      – PersonEntity:
          Name:
            NameFull: Burrows FJ
      – PersonEntity:
          Name:
            NameFull: Anderson KC
      – PersonEntity:
          Name:
            NameFull: Reich SD
      – PersonEntity:
          Name:
            NameFull: Richardson PG
      – PersonEntity:
          Name:
            NameFull: Trikha M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2016 Sep
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2141
          Numbering:
            – Type: volume
              Value: 174
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: British journal of haematology
              Type: main
ResultId 1